Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins for stroke prevention.

Larry B Goldstein1

  • 1Duke Center for Cerebrovascular Disease, Stroke Policy Program, Center for Clinical Health Policy Research, Box 3651, Duke University Medical Center, Durham, NC 27710, USA. golds004@mc.duke.edu

Current Atherosclerosis Reports
|January 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatal Fat Embolism Syndrome Without Recognized Fracture in Patients With Duchenne Muscular Dystrophy: Two Case Reports.

Pediatric neurology·2026
Same author

Advances in Stroke 2026: Treatments-Preventive.

Stroke·2026
Same author

Nonoperative management of patients with symptomatic carotid stenosis.

Seminars in vascular surgery·2026
Same author

Nonketotic Hyperglycinemia in Central and Appalachian Kentucky.

Journal of child neurology·2026
Same author

Alzheimer's Imaging Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Alzheimer's Imaging Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.

Current atherosclerosis reports·2026
Same journal

Targeting LDL Across the Whole Spectrum of Chronic Kidney Disease: From Pathophysiology to Novel Treatments.

Current atherosclerosis reports·2026
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
See all related articles

Cholesterol levels have a weak link to overall stroke risk, but statin treatment can reduce stroke risk in high-risk patients. Further research is needed to understand the mechanisms behind statin benefits.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Cholesterol's role in stroke risk is complex and inconsistent compared to coronary heart disease.
  • Specific cholesterol types show differing associations with ischemic and hemorrhagic stroke.

Purpose of the Study:

  • To review the relationship between cholesterol levels and stroke risk.
  • To evaluate the impact of statin therapy on stroke risk reduction.

Main Methods:

  • Analysis of epidemiologic studies on cholesterol and stroke.
  • Review of clinical trial data on statin treatment for stroke prevention.

Main Results:

  • Weak and inconsistent association between cholesterol and overall stroke risk.

Related Experiment Videos

  • Positive link between total/LDL cholesterol and ischemic stroke risk.
  • Inverse relationship between cholesterol and hemorrhagic stroke risk.
  • Statins reduce first stroke risk in high-risk populations.
  • Statins reduce cardiovascular events and stroke in patients with prior cerebrovascular disease.

    • Conclusions:

    • Statin therapy is associated with reduced stroke risk in various patient groups.
    • The precise mechanisms of statin-induced stroke risk reduction (lipid-lowering vs. pleiotropic effects) remain unclear from current clinical trial data.